PT
PT Kalbe Farma Tbk
PTKFY · OTC
$8.42 +0.36% (+$0.03)
1M -3.22%
Market Cap Rp 168.7B
P/E Ratio 0.05x
Div. Yield 2.67%
ROE 15.31%
Bulios Fair Price
$11.38
35.2% upside
Current Price
$8.42
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PTKFY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/FCF 0.07x
P/B 0.01x
P/E 0.05x
Growth
36 /100
Stable Book val. growth 4.57%
FCF growth 5.32%
EPS growth 3.61%
Profitability
57 /100
Moderate FCF margin 6.56%
Op. margin 12.14%
Gross margin 37.15%
Quality
79 /100
Excellent Asset turnover 1.15x
ROA 10.92%
ROIC 13.34%
Debt
100 /100
Low Net debt/EBITDA -0.75x
Int. coverage 122.27x
Debt/Equity 0.03x
Stability
71 /100
Stable Profitable years 6
EPS volatility 19.68%
Beta 0.05x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PTKFY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Bernadette Ruth Irawati Setiady
Employees
12,835
Headquarters
Jakarta